FDA Adverse Event Injury Summary report: N

OT ULTRA METER

MDR report key: 3171448 · Received June 15, 2013

Report

Report Number
3008382007-2013-17332
Event Type
Injury
Date Received
June 15, 2013
Date of Event
June 3, 2013
Report Date
June 3, 2013
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K062195
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

ON (B)(6) 2013, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) ALLEGING THAT HER ONETOUCH ULTRA METER READ INACCURATELY HIGH COMPARED TO HER FEELINGS AND/OR NORMAL RESULTS. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. THE PATIENT REPORTED THAT ON (B)(6) 2013, AT 8AM, SHE OBTAINED AN INACCURATE HIGH READING OF ¿358 MG/DL¿ WITH THE SUBJECT METER. THE PATIENT INFORMED THE CCA THAT SHE MANAGES HER DIABETES WITH ORAL MEDICATION(S), DIET AND/OR EXERCISE. IT IS NOT KNOWN IF THE PATIENT MADE ANY CHANGES TO HER USUAL DIABETES MANAGEMENT REGIMEN IN RESPONSE TO THE ELEVATED RESULT. THE PATIENT REPORTED FEELING SHAKY AND WEAK 45 MINUTES AFTER OBTAINING THE HIGH READING. THE PATIENT REPORTED TREATING HERSELF WITH GLUCOSE AND FOOD. AT THE TIME OF TROUBLESHOOTING, THE CCA NOTED THE PATIENT RAN A CONTROL SOLUTION TEST AND THE RESULT FELL WITHIN THE SPECIFIED CONTROL SOLUTION RANGE. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT REPORTEDLY DEVELOPED SYMPTOMS SUGGESTIVE OF SEVERE HYPOGLYCEMIA AFTER OBTAINING AN ALLEGED INACCURATE HIGH RESULT WITH THE LFS DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
272712 OT ULTRA METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3456254

Patients

Seq Age Sex Outcome Treatment
1 65 YR Life Threatening| R